Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

The test confirms the scientific validity of the biomarkers used in the lab, led by researcher Carleara Weiss, and increases ...

Americans are more likely to visit their eye doctor than their primary care provider. And that’s one big reason why a company ...

INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its ...

Evidence increasingly shows that chronic exposure to PM2.5, a neurotoxin, not only damages lungs and hearts but is also ...

Trump gave Maduro ultimatum to flee Venezuela as land operations loom: report Internet service providers warn of mass disconnections in Supreme Court battle with record labels Brian Walshe goes on ...

In August, Emma, 47, revealed the actor, 70, had moved into a separate one-story house down the street from their primary ...

The analysis, conducted by Pentara Corporation in collaboration with scientists from ProMIS, provides important new evidence that plasma phosphorylated tau (pTau181 and pTau217) can serve as a ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

Most people know which foods to avoid for a healthy heart. Yet, do you often think about the foods you eat and how they ...

Merck granted Fast Track Designation by the U.S. FDA for MK-2214 for the treatment of Alzheimer's disease RAHWAY, N.J., ...

By Ernie Mundell HealthDay ReporterMONDAY, Dec. 1, 2025 (HealthDay News) — Researchers say changes in folks' driving patterns ...